Skip to content

Lympholyte-H CL5015

by Cedarlane Corporation 2 variants

Lympholyte-H CL5015 is a medical device (FDA Class I; FDA product code JCF, Lymphocyte Separation Medium) made by Cedarlane Corporation, listed in FDA GUDID since 10 Dec 2024 (UDI-DI 00628451099024), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00628451099024 UDI-DI Date10 Dec 2024ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Lympholyte-H Cell Separation Media (Isolation of lymphocytes from Human peripheral blood), liquid
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Lympholyte-H
Generic name
Cell centrifugation/density gradient separation reagent IVD
Model / Ref / Catalog
CL5015
Primary DI / UDI-DI
00628451099024
FDA product code
JCF
GMDN term
Cell centrifugation/density gradient separation reagent IVD
Device class
Class I
Regulation number
864.8500
GUDID distribution status
In Commercial Distribution
Size
Total Volume — 100 Milliliter

Similar devices

Other devices filed under FDA product code JCF (Lymphocyte Separation Medium).

Other devices from Cedarlane Corporation

See all devices from Cedarlane Corporation →

Properties

  • Single use
  • Premarket exempt
Other properties (13, all answered No)